Fatty aldehyde bisulfite adducts as a purification handle in ionizable lipid synthesis

Graham Atwood,Sona Purbiya,Cassandra Reid,Brandon Smith,Kuljit Kaur,Drew Wicks,Peter Gaudet,K. Cory MacLeod,Jean-Francois Vincent-Rocan
DOI: https://doi.org/10.1039/d4ra05189k
IF: 4.036
2024-08-21
RSC Advances
Abstract:Rapid access to ALC-0315, a crucial component of the formulated Pfizer Covid vaccine, was obtained by employing solid adduct formation and filtration after an oxidation step in place of the standard chromatographic separation, allowing for a more scalable synthesis. Impurities were removed by formation of this fatty aldehyde bisulfite adduct at the penultimate step and by performing the final reductive amination directly with the fatty aldehyde bisulfite adduct. This eliminates chromatographic separations for all prepared aldehyde containing intermediates. Along with ALC-0315, FTT5 and SM-102 ionizable lipids were prepared utilizing this strategy. This work paves the way for more sustainable access to these critical ionizable lipids that would de-risk the world supply of important vaccines and medicines in the future.
chemistry, multidisciplinary
What problem does this paper attempt to address?